5,469
Views
2
CrossRef citations to date
0
Altmetric
Brief Report

Size distribution of exhaled aerosol particles containing SARS-CoV-2 RNA

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 158-163 | Received 05 Aug 2022, Accepted 22 Oct 2022, Published online: 04 Nov 2022

References

  • Adenaiye OO, Lai J, de Mesquita PJB, et al. Infectious SARS-CoV-2 in exhaled aerosols and efficacy of masks During early mild infection. Clin Infect Dis. 2021;75(1):e241–e248.
  • Coleman KK, Tay DJW, Sen Tan K, et al. Viral load of SARS-CoV-2 in respiratory aerosols emitted by COVID-19 patients while breathing, talking, and singing. Clin Infect Dis. 2021;74(10):1722–1728.
  • Alsved M, Nygren D, Thuresson S, et al. SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission. Clin Infect Dis. 2022;75(1):e50–e56.
  • Liu Y, Ning Z, Chen Y, et al. Aerodynamic analysis of SARS-CoV-2 in two wuhan hospitals. Nature. 2020;582(7813):557–560.
  • Santarpia JL, Herrera VL, Rivera DN, et al. The size and culturability of patient-generated SARS-CoV-2 aerosol. J Expo Sci Environ Epidemiol. 2022;32(5):706–711.
  • Stern RA, Al-Hemoud A, Alahmad B, et al. Levels and particle size distribution of airborne SARS-CoV-2 at a healthcare facility in Kuwait. Sci Total Environ. 2021;782:146799.
  • Stern RA, Koutrakis P, Martins MAG, et al. Characterization of hospital airborne SARS-CoV-2. Respir Res. 2021;22(1):73.
  • Marple VA, Olson BA, Santhanakrishnan K, et al. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: archival calibration. J Aerosol Med. 2003;16(3):301–324.
  • Thuresson S, Fraenkel C-J, Sasinovich S, et al. Airborne SARS-CoV-2 in hospitals–effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance. Clin Infect Dis. 2022;75(1):e89–e96.
  • Petrillo S, Carra G, Bottino P, et al. A novel multiplex qRT-PCR assay to detect SARS-CoV-2 infection: high sensitivity and increased testing capacity. Microorganisms. 2020;8(7):1064.
  • Lednicky JA, Lauzardo M, Alam MM, et al. Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness. Int J Infect Dis. 2021;108:212–216.
  • Alsved M, Matamis A, Bohlin R, et al. Exhaled respiratory particles during singing and talking. Aerosol Sci Technol. 2020;54(11):1245–1248.
  • Gregson FKA, Watson NA, Orton CM, et al. Comparing aerosol concentrations and particle size distributions generated by singing, speaking and breathing. Aerosol Sci Technol. 2021;55(6):681–691.
  • Leding C, Skov J, Uhrbrand K, et al. Detection of SARS-CoV-2 in exhaled breath from non-hospitalized COVID-19-infected individuals. Sci Rep. 2022;12(1):11151.
  • Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4(1):e2035057.
  • Ge Y, Martinez L, Sun S, et al. COVID-19 transmission dynamics among close contacts of index patients With COVID-19: a population-based cohort study in Zhejiang province, China. JAMA Intern Med. 2021;181(10):1343–1350.
  • Talic S, Shah S, Wild H, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. BMJ. 2021;375:e068302.
  • Milton DK, Fabian MP, Cowling BJ, et al. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013;9(3):e1003205.
  • Yang Q, Saldi TK, Gonzales PK, et al. Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities. Proc Natl Acad Sci U S A. 2021;118(21):e2104547118.
  • Jones TC, Biele G, Muhlemann B, et al. Estimating infectiousness throughout SARS-CoV-2 infection course. Science. 2021;373(6551):eabi5273.
  • Greenhalgh T, Jimenez JL, Prather KA, et al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603–1605.
  • Adam DC, Wu P, Wong JY, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020;26(11):1714–1719.